Document is current
Any future updates will be listed below
-
Authors
Nicholls, Stuart G. https://orcid.org/0000-0003-0485-9069
Nevins, Pascale https://orcid.org/0000-0002-4488-7366
Fox, Grace https://orcid.org/0000-0002-4039-4468
Vanderhout, Shelley https://orcid.org/0000-0001-6328-2680
Brehaut, Jamie https://orcid.org/0000-0002-4213-1143
Carroll, Kelly https://orcid.org/0000-0002-7367-0270
Fergusson, Dean https://orcid.org/0000-0002-3389-2485
Hilderley, Alicia https://orcid.org/0000-0002-2462-0234
MacArthur, Colin https://orcid.org/0000-0002-5029-0996
Potter, Beth K. https://orcid.org/0000-0001-8374-6542
Smith, Maureen https://orcid.org/0000-0002-2885-7028
Spinewine, Anne https://orcid.org/0000-0002-3836-2846
Weijer, Charles https://orcid.org/0000-0002-5510-1074
Taljaard, Monica https://orcid.org/0000-0002-3978-8961
- License Information
-
More Information
Article History
Received: 22 May 2025
Accepted: 26 September 2025
First Online: 11 December 2025
Declarations
:
: This study was approved by the Ottawa Health Science Network Research Ethics Board (Reference number: 20,210,684-01 H). All participants provided an implied consent by completing the survey.
: All authors have reviewed the manuscript and consent to publication.
: Charles Weijer reports receiving consulting fees from Eli Lilly & Company. Anne Spinewine reports receiving a Mobility Grant from Fondation Mont-Godinne. No other competing interests were declared.
